FDA Sets March 28 Date To Discuss Newly Published Draft User Fee Pact
This article was originally published in The Gray Sheet
Executive Summary
The agency published its draft commitment letter and draft legislative language for user fee reauthorization March 15. A public meeting is set for the end of the month, and public comments will be accepted through April 16.